Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of the efficacy and safety profile of morning administration of controlled-release simvastatin versus evening administration of immediate-release simvastatin in chronic kidney disease patients with dyslipidemia.
Yi YJ, Kim HJ, Jo SK, Kim SG, Song YR, Chung W, Han KH, Lee CH, Hwang YH, Oh KH. Yi YJ, et al. Among authors: lee ch. Clin Ther. 2014 Aug 1;36(8):1182-90. doi: 10.1016/j.clinthera.2014.06.005. Epub 2014 Jul 2. Clin Ther. 2014. PMID: 24996489 Free article. Clinical Trial.
Overhydration Negatively Affects Quality of Life in Peritoneal Dialysis Patients: Evidence from a Prospective Observational Study.
Yoon HE, Kwon YJ, Song HC, Kim JK, Song YR, Shin SJ, Kim HW, Lee CH, Lee TW, Kim YO, Kim BS, Moon KH, Chang YK, Kim SS, Bang K, Cho JT, Yun SR, Na KR, Kim YW, Han BG, Chung JH, Lee KY, Jeong JH, Hwang EA, Kim YS; Quality of Life of Dialysis Patients (QOLD) Study Group. Yoon HE, et al. Among authors: lee ch, lee ky, lee tw. Int J Med Sci. 2016 Aug 11;13(9):686-95. doi: 10.7150/ijms.16372. eCollection 2016. Int J Med Sci. 2016. PMID: 27647998 Free PMC article.
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study.
Kim Y, Park SK, Cho WY, Joo KW, Shin SK, Kim DJ, Kim YL, Son SH, Chung W, Lee KY, Park SK, Kim JK, Kim SW, Kang DH, Kim JK, Jeon JS, Lee KW, Lee CH, Oh DJ, An WS, Lee JS, Kang GW, Do JY, Lee JP, Jin K. Kim Y, et al. Among authors: lee ch, lee jp, lee js, lee kw, lee ky. BioDrugs. 2020 Feb;34(1):99-110. doi: 10.1007/s40259-019-00396-9. BioDrugs. 2020. PMID: 31749113 Clinical Trial.
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period.
Huh H, Kim YS, Chung W, Kim YL, Kim Y, Han S, Jung Y, Na KY, Lee KB, Oh YK, Park HC, Han SH, Yoo TH, Kim YH, Kim SW, Lee KW, Park HC, Kim SG, Kim H, Lee CH, Bae KT, Oh KH, Ahn C, Ryu HJ, Kim YC. Huh H, et al. Among authors: lee ch, lee kb, lee kw. Kidney Res Clin Pract. 2023 Mar;42(2):216-228. doi: 10.23876/j.krcp.22.024. Epub 2023 Jan 13. Kidney Res Clin Pract. 2023. PMID: 36634967 Free PMC article.
10,600 results
You have reached the last available page of results. Please see the User Guide for more information.